Skip to main content
SpringerLink
Log in

Mesothelioma

  • Chapter
Pathology of Asbestos-Associated Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 259.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stedman’s Medical Dictionary, 22nd ed. Baltimore: Williams & Wilkins, 1972.

    Google Scholar 

  2. Roggli VL, Kolbeck J, Sanfilippo F, Shelburne JD: Pathology of human mesothelioma: Etiologic and diagnostic considerations. Pathol Annu 22:91–131, 1987.

    PubMed  Google Scholar 

  3. Kuhn C: The cells of the lung and their organelles. In: The Biochemical Basis of Pulmonary Function (Crystal RG, ed.), New York: Marcel Dekker, 1976, pp. 3–48.

    Google Scholar 

  4. Davis JMG: The histopathology and ultrastructure of pleural mesotheliomas produced in the rat by injections of crocidolite asbestos. Br J Exp Pathol 60:642–652, 1979.

    CAS  PubMed  Google Scholar 

  5. Roggli VL, Oury TD, Moffatt EJ: Malignant mesothelioma in women. Anat Pathol 2:147–163, 1997.

    CAS  PubMed  Google Scholar 

  6. Browne K: Asbestos-related disorders. In: Occupational Lung Disorders, 3rd ed. (Parkes WR, ed.) London: Butterworths, 1994, pp. 411–504.

    Google Scholar 

  7. McDonald JC: Health implications of environmental exposure to asbestos. Environ Health Perspect 62:319–328, 1985.

    CAS  PubMed  Google Scholar 

  8. Spirtas R, Beebe GW, Connelly RR et al.: Recent trends in mesothelioma incidence in the United States. Am J Ind Med 9:397–407, 1986.

    CAS  PubMed  Google Scholar 

  9. McDonald AD, McDonald JC: Epidemiology of malignant mesothelioma. In: Asbestos-Related Malignancy (Antman K, Aisner J, eds.) Orlando: Harcourt Brace Jovanovich, 1987, pp. 31–55.

    Google Scholar 

  10. National Cancer Institute SEER Cancer Statistics review 1973–1993. Bethesda, MD: National Cancer Institute, 1996.

    Google Scholar 

  11. Battifora H, McCaughey WTE: Tumors of the serosal membranes. Atlas of Tumor Pathology, 3rd Series, Fascicle 15. Washington DC: Armed Forces Institute of Pathology, 1994.

    Google Scholar 

  12. Aisner J, Wiernick PH: Malignant mesothelioma: Current status and future prospects. Chest 74:438–443, 1978.

    CAS  PubMed  Google Scholar 

  13. Chahinian AP: Malignant mesothelioma. In: Cancer Medicine (Holland JF, Frei E III, eds.), Philadelphia: Lea & Febiger, 1982, pp. 1744–1751.

    Google Scholar 

  14. Wagner E: Das tuberkelahnliche lymphadenom. Arch d Heilkunde 11:497–526, 1870.

    Google Scholar 

  15. Hammar SP: Pleural diseases. Ch. 34 In: Pulmonary Pathology, 2nd ed. (Dail DH, Hammar SP, eds.), New York: Springer-Verlag, 1994, pp. 1463–1580.

    Google Scholar 

  16. Craighead JE: Eyes for the epidemiologist: The pathologist’s role in shaping our understanding of the asbestos-associated diseases. Am J Clin Pathol 89:281–287, 1988.

    CAS  PubMed  Google Scholar 

  17. Robertson HE: “Endothelioma” of the pleura. J Cancer Res 8:317–375, 1924.

    Google Scholar 

  18. Klemperer P, Rabin CB: Primary neoplasms of the pleura: Report of five cases. Arch Pathol 11:385–412, 1931.

    Google Scholar 

  19. McCaughey WTE, Kannerstein M, Churg J: Tumors and pseudotumors of the serosal membranes. Atlas of Tumor Pathology, 2nd Series, Fascicle 20. Washington DC: Armed Forces Institute of Pathology, 1985.

    Google Scholar 

  20. Castleman BI: Asbestos: Medical and Legal Aspects. New York: Harcourt Brace Jovanovich, 1984.

    Google Scholar 

  21. Gloyne SR: The morbid anatomy and histology of asbestosis. Tubercle 14:550–558, 1933.

    Article  CAS  Google Scholar 

  22. Wedler HW: Uber den Lungenkrebs bei Asbestose. Deutsch Arch Klin Med 191:189–209, 1943.

    Google Scholar 

  23. Mallory TB, Castleman B, Parris EE: Case records of the Massachusetts General Hospital # 33111. N Engl J Med 236:407–412, 1947.

    Article  Google Scholar 

  24. ZLee DHK, Selikoff IJ: Historical background to the asbestos problem. Environ Res 18:300–314, 1979.

    Article  CAS  PubMed  Google Scholar 

  25. Keal EE: Asbestosis and abdominal neoplasms. Lancet 2:1211–1216, 1960.

    Article  CAS  PubMed  Google Scholar 

  26. Wagner JC, Sleggs CA, Marchand P: Diffuse pleural mesothelioma and asbestos exposure in Northwestern Cape Province. Br J Ind Med 17:260–271, 1960.

    CAS  PubMed  Google Scholar 

  27. Edge JR, Choudhoury SL: Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax 33:26–30, 1978.

    CAS  PubMed  Google Scholar 

  28. McDonald AD, McDonald JC: Malignant mesothelioma in North America. Cancer 46:1650–1656, 1980.

    CAS  PubMed  Google Scholar 

  29. Otto H: Das berufsbedingte Mesotheliom in der BRD. Pathologe 2:8–18, 1980.

    CAS  PubMed  Google Scholar 

  30. Churg A: Malignant mesothelioma in British Columbia in 1982. Cancer 5:672–674, 1985.

    Google Scholar 

  31. Andersson M, Olsen JH: Trend and distribution of mesothelioma in Denmark. Br J Cancer 51:699–705, 1985.

    CAS  PubMed  Google Scholar 

  32. Malker HSR, McLaughlin JK, Malker BK: Occupational risks for pleural mesotheliomas in Sweden, 1961–79. J Natl Cancer Inst 74:61–66, 1985.

    CAS  PubMed  Google Scholar 

  33. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF: Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78:1053–1060, 1987.

    CAS  PubMed  Google Scholar 

  34. Ferguson DA, Berry G, Jelihovsky T: The Australian Mesothelioma Surveillance Program 1979–1985. Med J Australia 147:166–172, 1987.

    CAS  PubMed  Google Scholar 

  35. Elmes PC, McCaughey WTE, Wade OL: Diffuse mesothelioma of the pleura and asbestos. Br Med J 1:350–353, 1965.

    PubMed  CAS  Google Scholar 

  36. Newhouse ML, Thompson H: Mesothelioma of the pleura and peritoneum following exposure to asbestos in London area. Br J Ind Med 22:261–269, 1965.

    CAS  PubMed  Google Scholar 

  37. McEwen I, Finlayson A, Mair A: Mesothelioma in Scotland. Br Med J 4:575–578, 1970.

    CAS  PubMed  Google Scholar 

  38. McDonald AD, Harper A, El Attar OA: Epidemiology of primary malignant mesothelial tumors in Canada. Cancer 26:914–919, 1970.

    CAS  PubMed  Google Scholar 

  39. Rubino GF, Scansetti G, Donna A: Epidemiology of pleural mesothelioma in northwestern Italy (Piedmont). Br J Ind Med 29:436, 1972.

    CAS  PubMed  Google Scholar 

  40. Ashcroft T: Epidemiologic and quantitative relationships between mesothelioma and asbestos on Tyneside. J Clin Pathol 26:832–840, 1973.

    CAS  PubMed  Google Scholar 

  41. Hain E, Dalquen P, Bohlig H: Retrospective study of 150 cases of mesothelioma in the Hamburg area. Arch Arbeitsmed 33:15–37, 1974.

    Article  CAS  Google Scholar 

  42. Zielhuis RL, Versteeg JPJ, Planteydt HT: Pleural mesothelioma and exposure to asbestos: A retrospective case control study in the Netherlands. Arch Occup Environ Health 36:1–18, 1975.

    Article  CAS  Google Scholar 

  43. Britton M: The epidemiology of mesothelioma. Semin Oncol 29:18–25, 2002.

    Article  PubMed  Google Scholar 

  44. Sheers G, Coles RM: Mesothelioma risks in a naval dockyard. Arch Environ Health 35:276–282, 1980.

    CAS  PubMed  Google Scholar 

  45. Selikoff IJ, Hammond EC, Seidman H: Mortality experience of insulation workers in the United States and Canada, 1943–1976, In: Health hazards of asbestos exposure (Selikoff IJ, Hammond EC, eds.), Ann NY Acad Sci 330:91–116, 1979.

    Google Scholar 

  46. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ: Malignant mesothelioma in a cohort of asbestos insulation workers: Clinical presentation, diagnosis, and causes of death. Br J Ind Med 45:182–187, 1988.

    CAS  PubMed  Google Scholar 

  47. Churg A: Analysis of asbestos fibers from lung tissue: Research and diagnostic uses. Sem Respir Med 7:281–288, 1986.

    Article  Google Scholar 

  48. Schenker MB, Garshick E, Munoz A, Woskie SR, Speizer FE: A population-based case-control study of mesothelioma deaths among U.S. railroad workers. Am Rev Respir Dis 134:461–465, 1986.

    CAS  PubMed  Google Scholar 

  49. Mancuso TF: Relative risk of mesothelioma among railroad machinists exposed to chrysotile. Am J Ind Med 13:639–657, 1988.

    CAS  PubMed  Google Scholar 

  50. Wolf KM, Piotrowski ZH, Engel JD, et al. Malignant mesotheliomas with occupational and environmental asbestos exposure in an Illinois community hospital. Arch Intern Med 147:2145–2149, 1987.

    Article  CAS  PubMed  Google Scholar 

  51. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT: Malignant mesothelioma and occupational exposure to asbestos: A clinicopathologic correlation of 1445 cases. Ultrastruct Pathol 26:1–11, 2002.

    Article  Google Scholar 

  52. Antman KH: Malignant mesothelioma. N Engl J Med 303:200–202, 1980.

    Article  CAS  PubMed  Google Scholar 

  53. Craighead JE, Mossman BT: Pathogenesis of asbestos-associated diseases. N Engl J Med 306:1446–1455, 1982.

    Article  CAS  PubMed  Google Scholar 

  54. Talcott J, Thurber W, Gaensler E, Antman K, Li FP: Mesothelioma in manufacturers of asbestos-containing cigarette filters. Lancet I:392, 1987.

    Article  Google Scholar 

  55. Driscoll RJ, Mulligan WJ, Schultz D, Candelaria A: Malignant mesothelioma: A cluster in a Native American pueblo. N Engl J Med 318:1437–1438, 1988.

    Article  CAS  PubMed  Google Scholar 

  56. Li FP, Dreyfus MG, Antman K: Asbestos-contaminated nappies and familial mesothelioma. Lancet I:909–910, 1989

    Article  Google Scholar 

  57. National Research Council. Non-occupational risks of asbestiform fibers. Washington, DC: National Academy Press, 1984.

    Google Scholar 

  58. McDonald AD, McDonald JC: Mesothelioma after crocidolite exposure during gas mask manufacture. Environ Res 17:340–347, 1978.

    Article  CAS  PubMed  Google Scholar 

  59. Selikoff IJ, Hammond EC, Seidman H: Latency of asbestos disease among insulation workers in the United States and Canada. Cancer 46:2736–2740, 1980.

    CAS  PubMed  Google Scholar 

  60. Churg A: Neoplastic asbestos-induced disease. Ch. 10 In: Pathology of Occupational Lung Disease, 2nd ed. (Churg A, Green FHY, eds.), Baltimore: Williams & Wilkins, 1998, pp. 339–392.

    Google Scholar 

  61. Peto J, Seidman H, Selikoff IJ: Mesothelioma mortality in asbestos workers: Implictions for models of carcinogenesis and risk assessment. Br J Cancer 45:124–135, 1982.

    CAS  PubMed  Google Scholar 

  62. Chronic Hazard Advisory Panel on Asbestos: Report to the U.S. Consumer Product Safety Commission, Directorate for Health Sciences, Washington, DC, 1983.

    Google Scholar 

  63. Browne K, Smither WJ: Asbestos-related mesothelioma: Factors discriminating between pleural and peritoneal sites. Br J Ind Med 40:145–152, 1983.

    CAS  PubMed  Google Scholar 

  64. Jarvholm B, Sanden A: Lung cancer and mesothelioma in the pleura and peritoneum among Swedish insulation workers. Occup Environ Med 55:766–770, 1998.

    CAS  PubMed  Google Scholar 

  65. Roggli VL: Malignant mesothelioma and duration of asbestos exposure: Correlation with tissue mineral fiber content. Ann Occup Hyg 39:363–374, 1995.

    Article  CAS  PubMed  Google Scholar 

  66. Roggli VL, Pratt PC, Brody AR: Asbestos fiber types in malignant mesothelioma: An analytical scanning electron microscopic study. Am J Ind Med 23:605–614, 1993.

    CAS  PubMed  Google Scholar 

  67. Dunnigan J: Linking chrysotile asbestos with mesothelioma. Am J Ind Med 14:205–209, 1988.

    CAS  PubMed  Google Scholar 

  68. Churg A: On Dr. Dunnigan’s commentary linking chrysotile asbestos with mesothelioma. Am J Ind Med 14:235–238, 1988.

    CAS  PubMed  Google Scholar 

  69. Becklake MR: On Dr Dunnigan’s commentary linking chrysotile as bestos with mesothelioma. Am J Ind Med 14:239–240, 1988.

    CAS  PubMed  Google Scholar 

  70. Craighead JE: Response to Dr Dunnigan’s commentary. Am J Ind Med 14:241–243, 1988.

    CAS  PubMed  Google Scholar 

  71. Roggli VL, Pratt PC: Amphiboles and chrysotile asbestos exposure. Am J Ind Med 14:245–246, 1988.

    CAS  PubMed  Google Scholar 

  72. McDonald JC: Tremolite, other amphiboles, and mesothelioma. Am J Ind Med 14:247–249, 1988.

    CAS  PubMed  Google Scholar 

  73. Churg A, Wright JL, Vedal S: Fiber burden and patterns of disease in long term chrysotile miners and millers. Am Rev Respir Dis 148:25–31, 1993.

    CAS  PubMed  Google Scholar 

  74. Churg A, DiPaoli L, Kempe B, Stevens B: Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis 130:1042–1045, 1984.

    CAS  PubMed  Google Scholar 

  75. Dufresne A, Begin R, Churg A, Masse S. Mineral fibre content of lungs in mesothelioma cases seeking compensation in Quebec. Am J Respir Crit Care Med 153:711–718, 1996.

    CAS  PubMed  Google Scholar 

  76. Churg A. Chrysotile, tremolite and mesothelioma in man. Chest 93:621–628, 1988.

    CAS  PubMed  Google Scholar 

  77. Wagner JC, Berry G, Pooley FD: Mesotheliomas and asbestos type in asbestos textile workers: A study of lung contents. Br Med J 285:603–606, 1982

    Article  CAS  Google Scholar 

  78. Green FHY, Harley R, Vallyathan V, et al.: Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos textile workers. Occup Environ Med 54:549–559, 1997.

    CAS  PubMed  Google Scholar 

  79. McDonald AD, McDonald JC, Pooley FD: Mineral fiber content of lung in mesothelial tumors in North America. Ann Occup Hyg 26:417–422, 1982.

    CAS  PubMed  Google Scholar 

  80. Karjalainen A, Meurman LO, Pukkala E: Four cases of mesothelioma among Finnish anthophyllite miners. Occup Environ Med 51:212–215, 1994.

    CAS  PubMed  Google Scholar 

  81. Carbone M, Kratzke RA, Testa JR: The pathogenesis of mesothelioma. Semin Oncol 29:2–17, 2002.

    Article  CAS  PubMed  Google Scholar 

  82. Baris YL, Artvinli M, Sahin AA: Environmental mesothelioma in Turkey. Ann NY Acad Sci 330:423–432, 1979.

    CAS  PubMed  Google Scholar 

  83. Coplu L, Dumortier P, Demir AU, et al.: An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos. J Environ Pathol 15:177–182, 1982.

    Google Scholar 

  84. Zeren EH, Gumurdulu D, Roggli VL, Zorludemir S, Erkisi M, Tuncer I: Environmental malignant mesothelioma in Southern Anatolia: A study of 50 cases. Environ Hlth Persp 108:1047–1050, 2000.

    CAS  Google Scholar 

  85. Pooley FD: Evaluation of fiber samples taken from the vicinity of two villages in Turkey. In: Dusts and Disease: Occupational and Environmental Exposures to Selected Fibrous and Particulate Dusts (Lemen R, Dement JM, eds.), Park Forest South, IL: Pathotox Publishing, 1979, pp. 41–44.

    Google Scholar 

  86. Sebastien P, Gaudichet A, Bignon J, Baris YI: Zeolite bodies in human lungs from Turkey. Lab Invest 44:420–425, 1981.

    CAS  PubMed  Google Scholar 

  87. Rohl AN, Langer AM, Moncure G, Selikoff IJ, Fischbein A: Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey. Science 216:518–520, 1982.

    CAS  PubMed  Google Scholar 

  88. Maltoni C, Minardi F, Morisi L: Pleural mesotheliomas in Sprague Dawley rats by erionite: First experimental evidence. Environ Res 29:238–244, 1982.

    Article  CAS  PubMed  Google Scholar 

  89. Suzuki Y, Kohyama N: Malignant mesothelioma induced by asbestos in the mouse peritoneal cavity. Environ Res 35:277–292, 1984.

    Article  CAS  PubMed  Google Scholar 

  90. Fraire AE, Greenberg SD, Spjut HJ, Dodson RF, Williams G, Lach-Pasko E, Roggli VL: Effect of erionite upon the pleural mesothelium of the Fischer 344 rat. Chest 111:1375–1380, 1997.

    CAS  PubMed  Google Scholar 

  91. Roushdy-Hammady I, Siegel J, Emri S, et al.: Genetic susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357:444–445, 2001.

    Article  CAS  PubMed  Google Scholar 

  92. Peterson JT, Greenberg SD, Buffler PA: Non-asbestos related mesothelioma: A review. Cancer 54:367–369, 1984.

    Google Scholar 

  93. Gilks B, Hegedus C, Freeman H, et al.: Malignant mesothelioma after remote abdominal radiation. Cancer 61:2019–2021, 1988.

    CAS  PubMed  Google Scholar 

  94. Maurer R, Egloff B: Malignant peritoneal mesothelioma after cholangiography with thorotrast. Cancer 36:1381–1385, 1975.

    CAS  PubMed  Google Scholar 

  95. Antman KH, Ruxer RL, Aisner J, Vawter G: Mesothelioma following Wilms’ tumor in childhood. Cancer 54:367–369, 1984.

    CAS  PubMed  Google Scholar 

  96. Anderson KA, Hurley WC, Hurley BT, Ohrt DW: Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer 56:273–276, 1985.

    CAS  PubMed  Google Scholar 

  97. Austin MB, Fechner RE, Roggli VL: Pleural malignant mesothelioma following Wilms’ tumor. Am J Clin Pathol 86:227–230, 1986.

    CAS  PubMed  Google Scholar 

  98. Neugut AI, Ahsan H, Antman K: Incidence of malignant pleural mesothelioma after thoracic radiation therapy. Cancer 80:948–950, 1997.

    Article  CAS  PubMed  Google Scholar 

  99. Sanders CI, Jackson TA: Induction of mesotheliomas and sarcomas from hotspots of 239 PuO2 activity. Health Phys 22:755–759, 1972.

    CAS  PubMed  Google Scholar 

  100. Melato M, Rizzardi C: Malignant pleural mesothelioma after chemotherapy for breast cancer. Anticancer Res 21:3093–3096, 2001.

    CAS  PubMed  Google Scholar 

  101. Carbone M, Pass HI, Rizzo P: Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 9:1781–1790, 1994.

    CAS  PubMed  Google Scholar 

  102. Testa JR, Carbone M, Hirvonen A: A multiinstitutional study confirms the presence of and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res 58:4505–4509, 1998.

    CAS  PubMed  Google Scholar 

  103. Jasani B, Cristaudo A, Emri SA: Association of SV40 with human tumors. Semin Cancer Biol 11:43–61, 2001.

    Article  CAS  Google Scholar 

  104. Cicala C, Pompetti F, Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol 42:1524–1533, 1993.

    Google Scholar 

  105. Carbone M, Fisher S, Powers A, et al.: New molecular and epidemiologic issues in mesothelioma: Role of SV 40. J Cell Physiol 180:167–172, 1999.

    Article  CAS  PubMed  Google Scholar 

  106. Kops SP: Oral polio vaccine and human cancer: A reassessment of SV40 as a contaminant based upon legal documents. Anticancer Res 20:4745–4750, 2000.

    CAS  PubMed  Google Scholar 

  107. Rizzo P, Di Resta I, Powers A: Unique strains of SV40 in commercial polio vaccines from 1955 not readily identifiable with current testing for SV40 infection. Cancer Res 59:6103–6108, 1999.

    CAS  PubMed  Google Scholar 

  108. Mossman BT, Gruenert DC: SV40, growth factors and mesothelioma: Another piece of the puzzle. Am J Respir Cell Mol Biol 26:167–170, 2002.

    CAS  PubMed  Google Scholar 

  109. Carbone M, Rizzo P, Grimley A: Simian virus 40 large-T antigen binds p53 in human mesotheliomas. Nat Med 3:908–912, 1997.

    Article  CAS  PubMed  Google Scholar 

  110. DeLuca A, Baldi V, Esposito CM: The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus 40 large T-antigen in human mesotheliomas. Nat Med 3:913–916, 1997.

    Article  CAS  Google Scholar 

  111. Bocchetta M, Di Resta A, Powers R: Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci USA 97:10214–10219, 2000.

    Article  CAS  PubMed  Google Scholar 

  112. Klein G, Powers A, Croce C: Association of SV40 with human tumors. Oncogene 21:1141–1149, 2002.

    Article  CAS  PubMed  Google Scholar 

  113. Pass H, Donington P, Wu P, Rizzo M: Human mesotheliomas contain the simian virus 40 regulatory region and large tumor antigen DNA sequences. J Thorac Cardiovasc Surg 116:854–859, 1998.

    Article  CAS  PubMed  Google Scholar 

  114. Caccioti P, Strizzi L, Vianale G: The presence of simian virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am J Respir Cell Mol Biol 26:189–193, 2002.

    Google Scholar 

  115. Shivapurkar N, Wiethege I, Wistuba E: Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 76:181–188, 1999.

    Article  CAS  PubMed  Google Scholar 

  116. Toyoka S, Pass H, Shivapurkar Y: Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 61:5727–5730, 2001.

    Google Scholar 

  117. Hirvonen A, Mattson K, Karjalainen A: SV40-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40 contaminated polio vaccines. Mol Carcinogen 26:93–99, 1999.

    Article  CAS  Google Scholar 

  118. Hubner R, Van ME: Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). Cancer Causes Control 13:121–129, 2002.

    Article  PubMed  Google Scholar 

  119. Pilatte Y, Vivo C, Renier A: Absence of SV40 large T-antigen expression in human mesothelioma cell lines. Am J Respir Cell Mol Biol 23:788–793, 2000.

    CAS  PubMed  Google Scholar 

  120. Nelson, NJ: Debate on the link between SV40 and human cancer continues. J Nat Cancer Inst 93:1284–1286, 2001.

    Article  CAS  PubMed  Google Scholar 

  121. Strickler HD, Goedert JJ, Bueno R: A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiol Biomarkers Prev 10:523–532, 2001.

    CAS  PubMed  Google Scholar 

  122. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF, Goedert JJ: Contamination of poliovirus vaccines with simian virus 40 (1955–963) and subsequent cancer rates. JAMA 279:292–295, 1998.

    Article  CAS  PubMed  Google Scholar 

  123. Hillerdal G, Berg J: Malignant mesothelioma secondary to chronic inflammation and old scars: 2 cases and a review of the literature. Cancer 55:1968–1972, 1985.

    CAS  PubMed  Google Scholar 

  124. Riddell RH, Goodman MJ, Moosa AR: Peritoneal malignant mesothelioma in a patient with recurrent peritonitis. Cancer 48:134–139, 1981.

    CAS  PubMed  Google Scholar 

  125. Roggli VL, McGavran MH, Subach JA, Sybers HD, Greenberg SD: Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: A study of 25 cases. Cancer 50:2423–2432, 1982.

    CAS  PubMed  Google Scholar 

  126. Gold C: A primary mesothelioma involving the rectovaginal septum and associated with beryllium. J Path Bact 93:435–442, 1967.

    Article  CAS  PubMed  Google Scholar 

  127. Newman RH: Fine biogenic particulate silica fibres in sugarcane: a possible hazard. Ann Occup Hyg 30:365–370, 1986.

    CAS  PubMed  Google Scholar 

  128. Risberg B, Nickels J, Wagermark J: Familial clustering of malignant mesothelioma. Cancer 45:2422–2427, 1980.

    CAS  PubMed  Google Scholar 

  129. Lynch HT, Katz D, Marvicka SE: Familial mesothelioma: Review and family study. Cancer Genet Cytogenet 15:25–35, 1985.

    Article  CAS  PubMed  Google Scholar 

  130. Hammar SP, Bockus D, Remington F, Freidman S, LaZerte G: Familial mesothelioma: A report of two families. Hum Pathol 20:107–112, 1989.

    Article  CAS  PubMed  Google Scholar 

  131. Dawson A, Gibbs AR, Browne K, Pooley FD, Griffiths DM: Familial mesotheliomas: Details of 17 cases with histopathologic findings and mineral analysis. Cancer 70:1183–1187, 1992.

    CAS  PubMed  Google Scholar 

  132. Attanoos RL, Gibbs AR: Pathology of malignant mesothelioma. Histopathology 30:403–418, 1997.

    Article  CAS  PubMed  Google Scholar 

  133. Otte KE, Sigstaard TI, Kjaerulff J: Malignant mesothelioma: Clustering in the family producing asbestos cement in their home. Br J Ind Med 47:10–13, 1990.

    CAS  PubMed  Google Scholar 

  134. Fraire AE, Cooper S, Greenberg SD, Buffler P, Langston C: Mesothelioma of childhood. Cancer 62:838–847, 1988.

    CAS  PubMed  Google Scholar 

  135. Nishioka H, Furusho K, Yasunaga T: Congenital mesothelioma: Case report and electron microscopic study. Eur J Pediatr 147:428–430, 1988.

    Article  CAS  PubMed  Google Scholar 

  136. Hillerdal G: Malignant mesothelioma 1982: Review of 4710 published cases. Br J Dis Chest 77:321–343, 1983.

    Article  CAS  PubMed  Google Scholar 

  137. Corson JM: Pathology of diffuse malignant pleural mesothelioma. Sem Thorac Cardiovasc Surg 9:347–355, 1997.

    CAS  Google Scholar 

  138. Boutin C, Rey F, Gouvernet J: Thoracoscopy in pleural mesotheliomas: A prospective study of 188 patients. Part 2. Prognosis and staging. Cancer 72:393–404, 1993.

    Google Scholar 

  139. McCaughey WTE: Criteria for the diagnosis of diffuse mesothelial tumors. Ann NY Acad Sci 132:603–613, 1965.

    CAS  PubMed  Google Scholar 

  140. Craighead JE, Abraham JL, Churg A, et al.: Pathology of asbestos-associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema (Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health). Arch Pathol Lab Med 106:544–596, 1982.

    CAS  PubMed  Google Scholar 

  141. Sahn SA: State of the Art: The pleura. Am Rev Respir Dis 138:184–234, 1988.

    CAS  PubMed  Google Scholar 

  142. Adams VI, Unni KK, Muhm JR, Jett JR, Ilstrup DM, Bernatz PE: Diffuse malignant mesothelioma of the pleura: Diagnosis and survival in 92 cases. Cancer 58:1540–1551, 1986.

    CAS  PubMed  Google Scholar 

  143. Obers VJ, Leiman G, Girdwood RW, Spiro FI: Primary malignant pleural tumors (mesotheliomas) presenting as localized masses: Fine needle aspiration cytologic findings, clinical and radiologic features and a review of the literature. Acta Cytol 32:567–575, 1988.

    CAS  PubMed  Google Scholar 

  144. Crotty TB, Myers JL, Katzenstein A-LA: Localized malignant mesothelioma: A clinicopathologic and flow cytometric study. Am J Surg Pathol 18:357–363, 1994.

    CAS  PubMed  Google Scholar 

  145. Solomons K, Polakow R, Marchand P: Diffuse malignant mesothelioma presenting as bilateral malignant lymphangitis. Thorax 40:682–683, 1985.

    CAS  PubMed  Google Scholar 

  146. Roberts G: Distant visceral metastases in pleural mesothelioma. Br J Dis Chest 70:246–250, 1976.

    Article  CAS  PubMed  Google Scholar 

  147. Elmes P, Simpson MJC: The clinical aspects of mesothelioma. Q J Med 179:427–429, 1976.

    Google Scholar 

  148. Marom EH, Erasmus JJ, Pass HI, Patz EF: The role of imaging in malignant pleural mesothelioma. Sem Oncol 29:26–35, 2002.

    Article  Google Scholar 

  149. Alexander E, Clark RA, Colley DP, Mitchell SE: CT of malignant pleural mesothelioma. Am J Roentgenol 137:287–291, 1981.

    CAS  Google Scholar 

  150. Mirvis S, Dutcher JP, Haney PJ, Whitley NO, Aisner J: CT of malignant pleural mesothelioma. Am J Roentgenol 140:665–670, 1983.

    CAS  Google Scholar 

  151. Lorigan JG, Libshitz HI: MR imaging of malignant pleural mesothelioma. J Comput Asst Tomogr 13:617–620, 1989.

    CAS  Google Scholar 

  152. Harwood TR, Gracey DR, Yokoo H: Pseudomesotheliomatous carcinomas of the lung: Avariant of peripheral lung cancer. Am J Clin Pathol 65:159–167, 1985.

    Google Scholar 

  153. Hammar SP: The pathology of benign and malignant pleural diseases. Chest Surg Clin N Am 4:405–430, 1994.

    CAS  PubMed  Google Scholar 

  154. Koss M, Travis W, Moran C, Hochholzer L: Pseudomesotheliomatous adenocarcinoma: A reappraisal. Sem Diagn Pathol 9:117–123, 1992.

    CAS  Google Scholar 

  155. Sporn TA, Butnor KJ, Roggli VL: Epithelioid hemangioendothelioma of the pleura: An aggressive vascular malignancy and clinical mimic of malignant mesothelioma. Histopathology 41 [Suppl 2]:173–177, 2002.

    Google Scholar 

  156. Zhang PJ, LiVolsi VA, Brooks JJ: Malignant epithelioid vascular tumors of the pleura: Report of a series and literature review. Hum Pathol 31:29–34, 2000.

    Article  CAS  PubMed  Google Scholar 

  157. Lin B, Colby T, Gown AM, et al.: Vascular tumors of the serosal membranes A report of 14 cases. Am J Surg Pathol 20:1431–1439, 1999.

    Article  Google Scholar 

  158. Attanoos RL, Suvarna SK, Rhead: Malignant vascular tumors of the pleura in “asbestos workers” and endothelial differentiation in mesothelioma. Thorax 55:860–863, 2000.

    Article  CAS  PubMed  Google Scholar 

  159. Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES: The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111:106–109, 1997.

    CAS  PubMed  Google Scholar 

  160. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E: World Health Organization International Histological Classification of Tumours: Histological Typing of Lung and Pleural Tumors. Berlin Heidelberg: Springer Verlag, pp. 51–54, 1999.

    Google Scholar 

  161. Kannerstein M, Churg J: Peritoneal mesothelioma. Hum Pathol 8:83–93, 1977.

    CAS  PubMed  Google Scholar 

  162. Churg J, Rosen SH, Moolten S: Histological characteristics of mesothelioma associated with asbestos. Ann NY Acad Sci 132:614–622, 1965.

    CAS  PubMed  Google Scholar 

  163. Mayall FG, Gibbs AR: The histology and immunohistochemistry of small cell mesotheliomas. Histopathology 20:47–51, 1992.

    CAS  PubMed  Google Scholar 

  164. Nascimento GA, Keeney GL, Fletcher CDM: Deciduoid peritoneal mesothelioma: An unusual phenotype affecting young females. Am J Surg Pathol 18:439–445, 1994.

    CAS  PubMed  Google Scholar 

  165. Puttagunta L, Vriend RA, Nguyen GK: Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change. Am J Surg Pathol 24:1440–1443, 2000.

    CAS  PubMed  Google Scholar 

  166. Ordonez NG: Epithelial mesothelioma with deciduoid features: Report of four cases. Am J Surg Pathol 24:816–823, 2000.

    Article  CAS  PubMed  Google Scholar 

  167. Shanks JH, Harris M, Banerjee SS, et al.: Mesotheliomas with deciduoid morphology: A morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 24:285–294, 2000.

    Article  CAS  PubMed  Google Scholar 

  168. Serio G, Scattone A, Pennella A, Giardina C, Musti M, Valente T, Pollice L: Malignant deciduoid mesothelioma of the pleura: Report of two cases with long survival. Histopathology 40:348–352, 2002.

    Article  CAS  PubMed  Google Scholar 

  169. Monaghan H, Al-Nafussi A: Deciduoid pleural mesothelioma. Histopathology 39:104–105, 2001.

    Article  CAS  PubMed  Google Scholar 

  170. Reis-Filho JS, Pope LZB, Milanezi F, Balderrama CMSR, Serapiao MJ, Schmitt FC: Primary epithelial malignant mesothelioma of the pleura with deciduoid features: Cytohistologic and immunohistochemical study. Diagn Cytopathol 26:117–122, 2002.

    Article  PubMed  Google Scholar 

  171. Henderson DW: Pleomorphic malignant mesothelioma. Histopathology 41 [Suppl 2]:149–154, 2002.

    Google Scholar 

  172. Daya D, McCaughey WT: Well differentiated papillary mesothelioma of the peritoneum: A clinicopathologic study of 22 cases. Cancer 65:292–296, 1990.

    CAS  PubMed  Google Scholar 

  173. Goldblum J, Hart WR: Localized and diffuse mesotheliomas of the genital tract and peritoneum in women: A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas and localized fibrous tumors. Am J Surg Pathol 19:1124–1137, 1995.

    CAS  PubMed  Google Scholar 

  174. Butnor KJ, Sporn TA, Hammar SP, Roggli VL: Well-differentiated papillary mesothelioma. Am J Surg Pathol 25:1304–1309, 2001.

    Article  CAS  PubMed  Google Scholar 

  175. Gallateau-Salle F: Well differentiated papillary mesothelioma. Histopathology 41 [Suppl 2]:154–156, 2002.

    Google Scholar 

  176. Yousem SA, Hochholzer L: Malignant mesotheliomas with osseous and cartilaginous differentiation. Arch Pathol Lab Med 111:62–66, 1987.

    CAS  PubMed  Google Scholar 

  177. Andrion A, Mazzucco G, Bernardi P, Mollo F: Sarcomatous tumor of the chest wall with osteochondroid differentiation: Evidence of mesothelial origin. Am J Surg Pathol 13:707–712, 1989.

    Article  CAS  PubMed  Google Scholar 

  178. Henderson DW, Attwood HD, Constance TJ, Shilkin KB, Steele RH: Lymphohistiocytoid mesothelioma: A rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol 12:367–384, 1988.

    CAS  PubMed  Google Scholar 

  179. Kannerstein M, Churg J: Desmoplastic diffuse mesothelioma. In: Progress in Surgical Pathology (Fenoglio CM, Wolff M, eds.), New York: Masson Pub., 1980, pp. 19–29.

    Google Scholar 

  180. Cantin R, Al-Jabi M, McCaughey WTE: Desmoplastic diffuse mesothelioma. Am J Surg Pathol 6:215–222, 1982.

    CAS  PubMed  Google Scholar 

  181. Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL: The diagnosis of desm oplastic malignant mesothelioma and its distinction from fibrous pleurisy: A histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 110:191–199, 1998.

    CAS  PubMed  Google Scholar 

  182. Stout A: Biological effects of asbestos. Ann NY Acad Sci 130:680–682, 1965.

    Google Scholar 

  183. Adams VI, Unni KK: Diffuse malignant mesothelioma of the pleura: Diagnostic criteria based on an autopsy study. Am J Clin Pathol 82:15–23, 1984.

    CAS  PubMed  Google Scholar 

  184. Churg A, Colby TV, Cagle PT, Corson JM, Gibbs AR, Gilks B, Grimes MM, Hammar SP, Roggli VL, Travis WD: The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24:1183–1200, 2000.

    CAS  PubMed  Google Scholar 

  185. Cagle P, Brown R, Lebovitz R: p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. Hum Pathol 5:443–448, 1994.

    Article  Google Scholar 

  186. Harrison RN: Sarcomatous pleural mesotheliomas and cerebral metastases: Case report and review of eight cases. Eur J Respir Dis 65:185–188, 1984.

    CAS  PubMed  Google Scholar 

  187. Huncharek M, Muscat J: Metastases in diffuse pleural mesotheliomas: Influence of histologic type. Thorax 42:897–898, 1987.

    CAS  PubMed  Google Scholar 

  188. Huncharek M, Smith K: Extrathoracic lymph node metastases in malignant pleural mesothelioma. Chest 93:443–444, 1988.

    CAS  PubMed  Google Scholar 

  189. Machin T, Mashiyama ET, Henderson JAM, McCaughey WTE: Bony metastases in desmoplastic pleural mesothelioma. Thorax 43:155–156, 1988.

    CAS  PubMed  Google Scholar 

  190. Waxler B, Eisenstein R, Battifora H: Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesotheliomas. Cancer 44: 221–227, 1979.

    CAS  PubMed  Google Scholar 

  191. MacDougall DB, Wang SE, Zidar BL: Mucin-positive epithelial mesothelioma. Arch Pathol Lab Med 116:874–880, 1992.

    CAS  PubMed  Google Scholar 

  192. Cooke DS, Attanoos RL, Jalloh SS, Gibbs AR: “Mucin-positive” epithelial mesotheliomas of the peritoneum: An unusual diagnostic pitfall. Histopathology 37:33–36, 1999.

    Article  Google Scholar 

  193. Hammar SP, Bockus DE, Remington FL, Rohrbach KA: Mucin-positive epithelial mesotheliomas: A histochemical, immunohistochemical and ultrastructural comparison with mucin-producing pulmonary adenocarcinoma. Ultrastruct Pathol 20:293–325, 1996.

    CAS  PubMed  Google Scholar 

  194. Wang NS, Huang SN, Gold P: Absence of carcinoembryonic antigen material in mesothelioma. Cancer 44:937–943, 1979.

    CAS  PubMed  Google Scholar 

  195. Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE: The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 121:235–247, 1985.

    CAS  PubMed  Google Scholar 

  196. Battifora H, Kopinski MI: Distinction of mesothelioma from adenocarcinoma: An immunohistochemical approach. Cancer 55:1679–1685, 1985.

    CAS  PubMed  Google Scholar 

  197. Gibbs AR, Harach R, Wagner JC, Jasani B: Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 40:91–95, 1985.

    CAS  PubMed  Google Scholar 

  198. Holden J, Churg A: Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol 8:277–279, 1984.

    CAS  PubMed  Google Scholar 

  199. Loosli H, Hurlimann J: Immunohistological study of malignant diffuse mesotheliomas of the pleura. Histopathology 8:793–803, 1984.

    CAS  PubMed  Google Scholar 

  200. van Muijen GNP, Ruiter DJ, Ponec M, Huiskens van der Mey C, Warnaar SO: Monoclonal antibodies with different specificities against cytokeratins: An immunohistochemical study of normal tissues and tumors. Am J Pathol 114:9–17, 1984.

    PubMed  Google Scholar 

  201. Bolen JW, Hammar SP, McNutt MA: Reactive and neoplastic serosal tissue: Alight-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 10:34–47, 1986.

    CAS  PubMed  Google Scholar 

  202. Montag AG, Pinkus GS, Corson JM: Keratin protein immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesotheliomas: An immunoperoxidase study of 30 cases. Hum Pathol 19:336–342, 1988.

    CAS  PubMed  Google Scholar 

  203. Epstein JI, Budin RE: Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: Implications for the diagnosis of desmoplastic mesothelioma. Hum Pathol 17:514–519, 1986.

    CAS  PubMed  Google Scholar 

  204. Cagle PT, Truong L, Roggli VL, Greenberg SD: Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms. Am J Clin Pathol 92:66–71, 1989.

    Google Scholar 

  205. Wick MR, Loy T, Mills SE: Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Hum Pathol 21:759–766, 1990.

    Article  CAS  PubMed  Google Scholar 

  206. Ordonez NG: Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 22:1215–1221, 1998.

    Article  CAS  PubMed  Google Scholar 

  207. Cury PM, Butcher DN, Fisher C: Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod Pathol 13:107–112, 2000.

    Article  CAS  PubMed  Google Scholar 

  208. Chu P, Wu E, Weiss LM: Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol 13:962–972, 2000.

    Article  CAS  PubMed  Google Scholar 

  209. Moran CA, Wick MR, Suster S: The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Sem Diagn Pathol 17:178–183, 2000.

    CAS  Google Scholar 

  210. Corson JM, Pinkus GS: Mesothelioma: profile of keratin and carcinoembryonic antigen: An immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinoma. Am J Pathol 108:80–87, 1982.

    CAS  PubMed  Google Scholar 

  211. Sheibani K, Battifora H, Burke JS: Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas: An immunohistologic analysis demonstrating the value of Leu M1 antigen. Am J Pathol 123: 212–219, 1986.

    CAS  PubMed  Google Scholar 

  212. Metzger J, Lamerz R, Permanetter W: Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Cardiovasc Surg 100:860–866, 1990.

    Google Scholar 

  213. Ordonez NG: The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 30:313–323, 1999.

    Article  CAS  PubMed  Google Scholar 

  214. Ordonez NG: Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma: Review and update. Am J Clin Pathol 112:75–89, 1989.

    Google Scholar 

  215. Latza U, Niedobitek G, Schwarting R: Ber-Ep4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43:213–219, 1990.

    CAS  PubMed  Google Scholar 

  216. Ordonez NG: Value of the BerEP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. Am J Clin Pathol 109:85–89, 1998.

    CAS  PubMed  Google Scholar 

  217. Arber DA, Weiss LM: CD15: A review. Appl Immunohistochem 1:17–30, 1993.

    CAS  Google Scholar 

  218. Sheibani K, Battifora H, Burke JS: LeuM1 antigen in human neoplasms: An immunohistochemical study of 400 cases. Am J Surg Pathol 10:227–236, 1986.

    CAS  PubMed  Google Scholar 

  219. Lefebvre MP, Rodriguez F, Schlom J: The application of a monoclonal antibody to the differentiation of benign and malignant mesothelial proliferations from adenocarcinoma. (abstr) Lab Invest 52:38A, 1985.

    Google Scholar 

  220. Szpak CA, Johnston WW, Roggli V: The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody, B72.3. Am J Pathol 122:252–260, 1986.

    CAS  PubMed  Google Scholar 

  221. Ordonez NG: The immunohistochemical diagnosis of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 13:276–291, 1985.

    Google Scholar 

  222. Riera JR, Astengo-Osuna C, Longmate JA, et al.: The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat induced epitope retrieval. Am J Surg Pathol 21:1409–1419, 1997.

    Article  CAS  PubMed  Google Scholar 

  223. Leong ASY, Vernon-Roberts E: The immunohistochemistry of malignant mesothelioma. Pathol Annu 29:157–179, 1994.

    PubMed  Google Scholar 

  224. Marshall RJ, Herbert A, Braye SG: Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma and reactive mesothelium. J Clin Pathol 37:1215–1221, 1984.

    CAS  PubMed  Google Scholar 

  225. Doglioni C, Dei Tos AP, Laurino L: Calretinin: A novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 20:1037–1046, 1996.

    Article  CAS  PubMed  Google Scholar 

  226. Leers MPG, Aarts MMJ, Theunissen PHMH: E-cadherin and calretinin: A useful combination of immunohistochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma. Histopathology 32:209–216, 1998.

    Article  CAS  PubMed  Google Scholar 

  227. Barberis MCP, Faleri M, Veronese S: Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol 41:1757–1761, 1997.

    CAS  PubMed  Google Scholar 

  228. Ordonez NG: Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol 11:929–933, 1998.

    CAS  PubMed  Google Scholar 

  229. Collins CL, Ordonez NG, Schaefer R: Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 141:827–833, 1992.

    CAS  PubMed  Google Scholar 

  230. Ordonez NG: The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: A comparative study with other commonly used antibodies. Am J Surg Pathol 21:1399–1408, 1997.

    Article  CAS  PubMed  Google Scholar 

  231. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM: Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol 23:107–116, 1992.

    Article  CAS  PubMed  Google Scholar 

  232. Miettinen M, Kobatich AJ: HBME-1: a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors. Appel Immunohistochem 3:115–122, 1995.

    Google Scholar 

  233. Takeichi M: Cadherin cell adhesion receptors as morphogenetic regulators. Science 251:1451–1455, 1991.

    CAS  PubMed  Google Scholar 

  234. Soler AP, Knudsen KA, Jaurand M-C: The differential expression of N-Cadherin and E-Cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol 26:1363–1369, 1995.

    Article  Google Scholar 

  235. Ordonez NG: Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesotheliomas from pulmonary and nonpulmonary adenocarcinomas. Am J Surg Pathol 24:598–606, 2000.

    Article  CAS  PubMed  Google Scholar 

  236. Soler AP, Knudsen KA, Teeson-Miguel A: Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. Hum Pathol 28:734–739, 1997.

    Article  Google Scholar 

  237. Bejarano PA, Baughman RP, Biddinger PW, et al.: Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol 9:445–452, 1996.

    CAS  PubMed  Google Scholar 

  238. Di Loreto C, Puglisi F, Di Luro V, Damante G, Beltrami CA: TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Letts 124:73–78, 1998.

    Article  Google Scholar 

  239. Wang NS: Electron microscopy in the diagnosis of pleural mesotheliomas. Cancer 31:1046–1054, 1973.

    CAS  PubMed  Google Scholar 

  240. Davis JMG: Ultrastructure of human mesotheliomas. J Natl Cancer Inst 52:1715–1725, 1974.

    CAS  PubMed  Google Scholar 

  241. Dardick I, El-Jabbi M, McCaughey WT, et al: Ultrastructure of poorly differentiated diffuse epithelial mesotheliomas. Ultrastruct Pathol 7:151–160, 1984.

    CAS  PubMed  Google Scholar 

  242. Warhol MJ, Hickey WF, Corson JM: Malignant mesothelioma: Ultrastructural distinction from adenocarcinoma. Am J Surg Pathol 6:307–314, 1982.

    CAS  PubMed  Google Scholar 

  243. Warhol MJ, Corson JM: An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast. Hum Pathol 16:50–55, 1985.

    CAS  PubMed  Google Scholar 

  244. Burns TR, Greenberg SD, Mace ML, Johnson EH: Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer 56:2036–2040, 1985.

    CAS  PubMed  Google Scholar 

  245. Dardick I, El-Jabbi M, McCaughey WT: Diffuse epithelial mesothelioma: A review of the ultrastructural spectrum. Ultrastruct Pathol 11:503–533, 1987.

    CAS  PubMed  Google Scholar 

  246. Oury TD, Hammar SP, Roggli VL: Ultrastructural features of diffuse malignant mesotheliomas. Hum Pathol 29:1382–1392, 1998.

    Article  CAS  PubMed  Google Scholar 

  247. Dewar A, Valente M, Ring NP, et al.: Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: An ultrastructural and cytochemical comparison. J Pathol 152:309–316, 1987.

    Article  CAS  PubMed  Google Scholar 

  248. Jandik WR, Landas SK, Bray CK, Lager DJ: Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas. Mod Pathol 6:761–764, 1993.

    CAS  PubMed  Google Scholar 

  249. Burns TR, Johnson EH, Cartwright J, Greenberg SD: Desmosomes of epithelial malignant mesothelioma. Ultrastruct Pathol 12:385–388, 1988.

    CAS  PubMed  Google Scholar 

  250. Ghadially FN, Rippstein PU: Giant desmosomes in tumors. Ultrastruct Pathol 19:469–474, 1995.

    CAS  PubMed  Google Scholar 

  251. Mukherjee TM, Swift JG, Henderson DW: Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumor). J Submicrosc Cytol Pathol 20:195–208, 1988.

    CAS  PubMed  Google Scholar 

  252. Roggli VL, Sanfilippo F, Shelburne JD: Mesothelioma. Ch. 5 In: Pathology of Asbestos-Associated Diseases (Roggli VL, Greenberg SD, Pratt PC, eds.), Boston: Little, Brown & Co., 1992, pp. 109–164.

    Google Scholar 

  253. Klima M, Bossart MI: Sarcomatous type of malignant mesothelioma. Ultrastruct Pathol 4:349–358, 1983.

    CAS  PubMed  Google Scholar 

  254. Ordonez NG, Ro JY, Ayala AG: Lesions described as nodular mesothelial hyperplasia are primarily composed of histiocytes. Am J Surg Pathol 22:285–292, 1998.

    Article  CAS  PubMed  Google Scholar 

  255. Taylor DR, Page W, Hughes D, Varghese G: Metastatic renal cell carcinoma mimicking pleural mesothelioma. Thorax 42:901–902, 1987.

    CAS  PubMed  Google Scholar 

  256. Weiss SW, Enzinger FM: Epithelioid hemangioendothelioma: A vascular tumor often mistaken for an adenocarcinoma. Cancer 50:970–981, 1982.

    CAS  PubMed  Google Scholar 

  257. Dail DH, Liebow AA, Gmelich JT: Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT): An analysis of twenty cases of a peculiar sclerosing endothelial tumor. Cancer 51:452–464, 1983.

    CAS  PubMed  Google Scholar 

  258. Corrin B, Manners B, Millard M, Weaver L: Histogenesis of the so-called “intravascular bronchioloalveolar tumor”. J Pathol 128:163–167, 1979.

    Article  CAS  PubMed  Google Scholar 

  259. Miettinen M, Limon J, Niezabitowski A, Lasota J: Calretinin and other mesothelioma markers in synovial sarcoma: Analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol 25:610–617, 2001.

    Article  CAS  PubMed  Google Scholar 

  260. Gaertner E, Zeren EH, Fleming MV, Colby TV, Travis WD: Biphasic synovial sarcomas arising in the pleural cavity: A clinicopathologic study of five cases. Am J Surg Pathol 20:36–45, 1996.

    Article  CAS  PubMed  Google Scholar 

  261. Aubry M-C, Bridge JA, Wickert R, Tazelaar HD: Primary monophasic synovial sarcoma of the pleura: Five cases confirmed by the presence of SYT-SSX fusion transcript. Am J Surg Pathol 25:776–781, 2001.

    Article  CAS  PubMed  Google Scholar 

  262. Praet M, Forsyth R, Dhaene K, Hermans G, Remmelinck M, Goethem JV, Verbeken E, Weynand B: Synovial sarcoma of the pleura: Report of four cases. Histopathology 41 [Suppl 2]:147–149, 2002.

    Google Scholar 

  263. De Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A: Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2 in t(8:18) (p1 1.2:q1 1.2) positive synovial sarcoma. Hum Mol Genet 4:1097–1099, 1995.

    PubMed  Google Scholar 

  264. Winslow TJ, Taylor HB: Malignant peritoneal mesotheliomas: A clinicopathological analysis of 12 fatal cases. Cancer 13:127–136, 1960.

    CAS  PubMed  Google Scholar 

  265. Whitley NO, Brenner DE, Antman KH, et al.: Computed tomographic evaluation of peritoneal mesothelioma: An analysis of eight cases. Am J Roentgenol 138:531–535, 1982.

    CAS  Google Scholar 

  266. Fukuda T, Hayashi K, Mori M, et al.: Radiologic manifestations of peritoneal mesothelioma. Nippon Igaku Hoshasen Gakkai Zasshi 51:643–647, 1991.

    CAS  PubMed  Google Scholar 

  267. Piccigallo E, Jeffers LJ, Reddy KR, Caldironi MW, Parenti A, Schiff ER: Malignant peritoneal mesothelioma: A clinical and laparoscopic study of ten cases. Dig Dis Sci 33:633–639, 1988.

    Article  CAS  PubMed  Google Scholar 

  268. Mennemeyer R, Smith M: Multicystic peritoneal mesothelioma: A report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma). Cancer 44:692–698, 1979.

    CAS  PubMed  Google Scholar 

  269. Moore JH, Crum CP, Chandler JG, Feldman PS: Benign cystic mesothelioma. Cancer 45:2395–2399, 1980.

    PubMed  Google Scholar 

  270. Weiss SW, Tavassoli FA: Multicystic mesothelioma: An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol 12:737–746, 1988.

    CAS  PubMed  Google Scholar 

  271. Ross MJ, Welsh WR, Scully RE: Multilocular peritoneal inclusion cysts (socalled cystic mesothelioma). Cancer 64:1326–1346, 1989.

    Google Scholar 

  272. Greengard O, Head JF, Chahinian AP, Goldberg SL: Enzyme pathology of human mesotheliomas. J Natl Cancer Inst 78:617–622, 1987.

    CAS  PubMed  Google Scholar 

  273. Talerman A, Montero JR, Chilcote RR, Okagaki T: Diffuse malignant peritoneal mesothelioma in a 13-year-old girl: Report of a case and review of the literature. Am J Surg Pathol 9:73–80, 1985.

    CAS  PubMed  Google Scholar 

  274. Santucci M, Biancalani M, Dini S: Multicystic peritoneal mesothelioma: A fine structure study with special reference to the spectrum of phenotypic differentiation exhibited by mesothelial cells. J Submicrosc Cytol Pathol 21:749–764, 1989.

    CAS  PubMed  Google Scholar 

  275. Rosai J: Peritoneum, Retroperitoneum, and Related Structures, Ch. 26, In: Ackerman’s Surgical Pathology, 8th ed. (Rosai J, ed.), St. Louis: Mosby, 1996, pp. 2135–2172.

    Google Scholar 

  276. Gilks CB, Bell DA, Scully RE: Serous psammocarcinoma of the ovary and peritoneum. Int J Gyn Pathol 9:110–121, 1990.

    CAS  Google Scholar 

  277. Chu PG, Weiss LM: Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases. Mod Pathol 15:6–10, 2002.

    Article  PubMed  Google Scholar 

  278. Armstrong GR, Raafat F, Ingram L, Mann JR: Malignant peritoneal mesothelioma in childhood. Arch Pathol Lab Med 112:1159–1162, 1988.

    CAS  PubMed  Google Scholar 

  279. Kerrigan SAJ, Turnnir RT, Clement PB, et al.: Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 patients. Cancer 94:378–385, 2002.

    Article  PubMed  Google Scholar 

  280. Hodgson JT, Darnton A: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 44:565–601, 2000.

    Article  CAS  PubMed  Google Scholar 

  281. Barbera V, Rubino M: Papillary mesothelioma of the tunica vaginalis. Cancer 10:182–189, 1957.

    Google Scholar 

  282. Jones MA, Young RH, Scully RE: Malignant mesothelioma of the tunica vaginalis: A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 19:815–825, 1995.

    Article  CAS  PubMed  Google Scholar 

  283. Plas E, Riedl CR, Pflueger H: Malignant mesothelioma of the tunica vaginalis testis: Review of the literature and assessment of prognostic parameters. Cancer 83:2437–2446, 1998.

    Article  CAS  PubMed  Google Scholar 

  284. Japko L, Horta AA, Schreiber K, Mitsudo S, Karwa GL, Singh G, Koss LG: Malignant mesothelioma of the tunica vaginalis testis: Report of first case with preoperative diagnosis. Cancer 49:119–127, 1982.

    CAS  PubMed  Google Scholar 

  285. Khan MA, Puri P, Devaney D: Mesothelioma of the tunica vaginalis testis in a child. J Urol 158:198–199, 1997.

    Article  CAS  PubMed  Google Scholar 

  286. Nochomowitz LE, Orenstein JM: Adenocarcinoma of the rete testis: Case report, ultrastructural observations and clinicopathologic correlates. Am J Surg Pathol 8:625–634, 1984.

    Google Scholar 

  287. Taxy JB, Battifora H, Ovasu R: Adenomatoid tumors: A light microscopic, histochemical and ultrastructural study. Cancer 34:306–316, 1974.

    CAS  PubMed  Google Scholar 

  288. Thompson R, Schlegel W, Lucca M: Primary malignant mesothelioma of the pericardium: Case report and literature review. Texas Heart Inst J 21:170–174, 1994.

    Google Scholar 

  289. Vigneswaran WT, Stefanacci PR: Pericardial mesothelioma. Curr Treat Options Oncol 1:299–302, 2000.

    CAS  PubMed  Google Scholar 

  290. Nomori H, Shimosato Y, Tsuchiya R: Diffuse malignant pericardial mesothelioma. Acta Pathol Jpn 35:1475–1481, 1985.

    CAS  PubMed  Google Scholar 

  291. Llewellyn MJ, Atkinson MW, Fabri B: Pericardial constriction caused by pericardial mesothelioma. Br Heart J 57:54–57, 1987.

    CAS  PubMed  Google Scholar 

  292. Nishikimi T, Ochi H, Hirota K, Ikuno Y, Oku H, Takeuchi K, Takeda T: Primary pericardial mesothelioma detected by gallium-67 scintigraphy. J Nucl Med 28:1210–1212, 1987.

    CAS  PubMed  Google Scholar 

  293. Gossinger HD, Siostrzonek P, Zangeneh M, Neuhold A, Herold C, Schmoliner R, Laczkovics A, Tscholakoff D, Mosslacher H: Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J 115:1321–1322, 1988.

    Article  CAS  PubMed  Google Scholar 

  294. Naramoto A, Itoh N, Nakano M, Shigematsu H: An autopsy case of tuberous sclerosis associated with primary pericardial mesothelioma. Acta Pathol Jpn 39:400–406, 1989.

    CAS  PubMed  Google Scholar 

  295. Burke A, Virmani R: Tumors of the heart and great vessels. In: Atlas of Tumor Pathology. Series 3, Fasc 16. Washington, DC: Armed Forces Institute of Pathology, 1996.

    Google Scholar 

  296. Smith C: Tumors of the heart. Arch Pathol Lab Med 110:371–374, 1986.

    CAS  PubMed  Google Scholar 

  297. Linder J, Shelburne JD, Sorge JP, Whalen RE, Hackel DB: Congenital endodermal heterotopia of the atrioventricular node: Evidence for the endodermal origin of so-called mesotheliomas of the atrioventricular node. Hum Pathol 15:1093–1098, 1984.

    CAS  PubMed  Google Scholar 

  298. Sopher IM, Spitz WU: Endodermal inclusions of the heart: So-called mesotheliomas of the atrioventricular node. Arch Pathol 92:180–186, 1971.

    CAS  PubMed  Google Scholar 

  299. Fine G, Raju U: Congenital polycystic tumor of the atrioventricular node (endodermal heterotopia, mesothelioma): A histogenetic appraisal with evidence for its endodermal origin. Hum Pathol 18:791–795, 1987.

    CAS  PubMed  Google Scholar 

  300. Beck B, Konetzke G, Ludwig V, et al.: Malignant pericardial mesotheliomas and asbestos exposure: A case report. Am J Ind Med 3:149–159, 1982.

    CAS  PubMed  Google Scholar 

  301. Kahn EI, Rohl A, Barnett EW, Suzuki Y: Primary pericardial mesothelioma following exposure to asbestos. Environ Res 23:270–281, 1980.

    Article  CAS  PubMed  Google Scholar 

  302. Churg A, Warnock ML, Bersch KG: Malignant mesothelioma arising after direct application of asbestos and fiberglass to the pericardium. Am Rev Respir Dis 118:419–424, 1978.

    CAS  PubMed  Google Scholar 

  303. Roggli VL: Pericardial mesothelioma after exposure to asbestos. N Engl J Med 304:1045, 1981.

    CAS  PubMed  Google Scholar 

  304. Steele JPC: Prognostic factors in mesothelioma. Semin Oncol 29:36–40, 2002.

    Article  PubMed  Google Scholar 

  305. Steele JPC, Rudd RM: Malignant mesothelioma: Predictors of prognosis and clinical trials. Thorax 55:725–726, 2000.

    Article  CAS  PubMed  Google Scholar 

  306. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM: Diffuse malignant mesothelioma: Prospective evaluation of 69 patients. Ann Int Med 96:746–755, 1982.

    CAS  PubMed  Google Scholar 

  307. Ruffie P, Feld R, Minkin S: Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 188 consecutive patients. Cancer 72:410–417, 1993.

    Google Scholar 

  308. Spirtas R, Connelly RR, Tucker MA: Survival patterns for malignant mesothelioma: The SEER experience. Int J Cancer 41:525–530, 1988.

    CAS  PubMed  Google Scholar 

  309. Herndon JE, Green MR, Chahinian AP: Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113:723–731, 1998.

    CAS  PubMed  Google Scholar 

  310. Curran D, Sahmoud T, Therasse P: Prognostic factors in patients with pleural mesotheliomas: The European Organization for Research and Treatment of Cancer experience. J Clin Oncol 16:145–152, 1998.

    CAS  PubMed  Google Scholar 

  311. Edwards JG, Abrams KR, Leverment JN: Prognostic factors for malignant mesothelioma in 142 patients: Validation of CALGB and EORTC prognostic scoring systems. Thorax 55:723–731, 2000.

    Article  Google Scholar 

  312. Antman K, Blum R, Greenberger J, et al.: Multimodality therapy for mesothelioma based on a study of natural history. Am J Med 68:356–362, 1980.

    Article  CAS  PubMed  Google Scholar 

  313. Antman KH: Current concepts: Malignant mesothelioma. N Engl J Med 303:200–202, 1980.

    Article  CAS  PubMed  Google Scholar 

  314. Ceresoli GL, Locati LdeB, Ferreri AJ: Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer 34:279–287, 2001.

    Article  CAS  PubMed  Google Scholar 

  315. Antman KH, Shemin R, Ryan L: Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades 1965–1985. J Clin Oncol 6:147–153, 1988.

    CAS  PubMed  Google Scholar 

  316. Butchart EG, Ashcroft T, Barnsley WC, Holden MP: Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: Experience with 29 patients. Thorax 31:15–24, 1976.

    Article  CAS  PubMed  Google Scholar 

  317. Sugarbaker DJ, Flores R, Jacklitsch M: Resection margins, extrapleural nodal status and cell type determine post-operative long term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117:54–65, 1999.

    Article  CAS  PubMed  Google Scholar 

  318. Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Chest 108:1122–1128, 1995.

    CAS  PubMed  Google Scholar 

  319. Lerner HJ, Schoenfeld DA, Martin AM, Falson G, Borden E: Malignant mesothelioma: The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 52:1981–1985, 1983.

    CAS  PubMed  Google Scholar 

  320. Moertel C: Peritoneal mesothelioma. Gastroenterology 63:346–350, 1972.

    CAS  PubMed  Google Scholar 

  321. Antman K, Klegar K, Pomfret EA, et al.: Early peritoneal mesothelioma: a treatable malignancy. Lancet 2:977–981, 1985.

    Article  CAS  PubMed  Google Scholar 

  322. Weissman L, Osteen R, Corson J: Combined modality therapy for intraperitoneal mesothelioma (abstr). Proc Am Soc Clin Oncol 7:274, 1988.

    Google Scholar 

  323. Antman K, Pomfret E, Aisner J: Peritoneal mesothelioma: Natural history and response to chemotherapy. J Clin Oncol 1:386–391, 1983.

    CAS  PubMed  Google Scholar 

  324. Sugarbaker PH, Acherman YIZ, Gonzalez-Moreno S, Ortega-Perez G: Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute Experience. Semin Oncol 29:51–61, 2002.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Thomas A. Sporn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor L. Roggli
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke University, Durham, North Carolina, 27710, USA

    Victor L. Roggli MD (Professor of Pathology) (Professor of Pathology)

  2. Durham VA Medical Centers, Durham, North Carolina, 27710, USA

    Victor L. Roggli MD (Professor of Pathology) (Professor of Pathology)

  3. Department of Pathology, Duke University Medical Center, Durham, NC, 27710, USA

    Thomas A. Sporn MD (Assistant Professor) (Assistant Professor)

  4. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA

    Tim D. Oury MD, PhD (Assistant Professor of Pathology) (Assistant Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Sporn, T.A., Roggli, V.L. (2004). Mesothelioma. In: Roggli, V.L., Sporn, T.A., Oury, T.D. (eds) Pathology of Asbestos-Associated Diseases. Springer, New York, NY. https://doi.org/10.1007/0-387-21819-X_5

Download citation

  • DOI: https://doi.org/10.1007/0-387-21819-X_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-20090-3

  • Online ISBN: 978-0-387-21819-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation